Literature DB >> 29658434

Bone Marrow-Derived Cells Trafficking to the Oviduct: Effect of Ischemia-Reperfusion Injury.

Cagdas Sahin1, Ramanaiah Mamillapalli1, Hugh S Taylor1.   

Abstract

The oviduct/fallopian tube is a crucial organ in the mammalian reproductive tract; it plays a critical role in gamete transportation and early embryo development. In women, torsion of the fallopian tubes can cause ischemia and reperfusion (IR) injury. In this study, we tested the effect of this injury on recruitment of bone marrow-derived cells (BMDCs) to the oviducts of reproductive age female mice. Bone marrow-derived cells were collected from ubiquitin-green fluorescent protein-positive male mice and transplanted into wild-type female mice. Ischemia and reperfusion injury was performed in half of the mice, while controls received equivalent surgery without oviduct injury. Two weeks following injury, recruitment of BMDCs to the oviducts was analyzed in both groups. Ischemia and reperfusion injury caused a greater than 2-fold increase in BMDC recruitment to the injured oviducts compared to those without injury. Specifically, the recruitment of BMDCs was localized to the stroma of the oviduct. We demonstrate that IR injury to oviduct recruits BMDCs to this tissue and suggest that BMDCs have function in the healing process.

Entities:  

Keywords:  bone marrow derived cells (BMDCs); fallopian tube; ischemia and reperfusion injury (IR injury); oviduct

Mesh:

Year:  2018        PMID: 29658434      PMCID: PMC6346346          DOI: 10.1177/1933719118770552

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  1 in total

1.  Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.

Authors:  Bingfeng Zheng; Manman Yuan; Qinhai Ma; Shenglan Wang; Yang Tan; Yizhu Xu; Jing Ye; Yanjie Gao; Xueqing Sun; Zifeng Yang; Peipei Xu; Lingdong Kong; Xingxin Wu; Qiang Xu
Journal:  Int Immunopharmacol       Date:  2021-03-10       Impact factor: 5.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.